370 - Toxoplasma gondii IgG Seropositivity is Associated with Increased Schizophrenia, Hospitalization, and 1-year Mortality— a Multicenter Research Network Study

Thursday, October 20, 2022

12:15 PM – 1:30 PM US ET

Location: Hall B + C

Co-Author(s)

GM

Gabrielle E. Montalbano, MD

University of Colorado
Denver, Colorado, United States
ER

Elaine Reno, MD

Assistant Professor
University of Colorado
Denver, Colorado, United States
MR

Marika Rossetto, MD

University of Colorado
Denver, Colorado, United States
AZ

Alexander Zhang, n/a

University of Colorado
Denver, Colorado, United States
Vanessa Kung, MD, PhD

ID Fellow
University of Colorado
Denver, Colorado, United States
Carlos Franco-Paredes, MD, MPH

Adjunct Professor
Hospital Infantil de México, Federico Gómez
Denver, Colorado, United States

Lilian Vargas Barahona, University of Colorado

Transplant Infectious Diseases Fellow
MD
Denver, Colorado, United States

Daniel B. Chastain, Pharm.D., BCIDP, AAHIVP

Clinical Associate Professor
University of Georgia College of Pharmacy
Albany, Georgia, United States
JM

Jose G Montoya, MD, FACP, FIDSA

National Reference Center for the Study and Diagnosis of Toxoplasmosis
Palo Alto, California, United States
AH

Andrés F. Henao-Martínez, MD

University of Colorado Anschutz Medical Campus
Aurora, Colorado, United States